tradingkey.logo

AstraZeneca 2025 sales outlook tops expectations

ReutersFeb 6, 2025 7:01 AM

- AstraZeneca AZN.L forecast its 2025 sales above analysts' expectations on Thursday, after the drugmaker's fourth-quarter revenue beat estimates, driven by robust demand, especially for its medicines for cancer and heart diseases.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI